|
1
|
Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis.
|
Haematologica
|
2005
|
2.12
|
|
2
|
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
|
J Hepatol
|
2008
|
1.85
|
|
3
|
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
|
J Gastroenterol
|
2004
|
1.83
|
|
4
|
Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
|
Am J Gastroenterol
|
2002
|
1.63
|
|
5
|
Current state of Wilson disease patients in central Japan.
|
Intern Med
|
2010
|
1.45
|
|
6
|
Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment.
|
Hepatol Res
|
2011
|
0.87
|
|
7
|
A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
|
Intern Med
|
2005
|
0.84
|
|
8
|
Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells.
|
Biochem Pharmacol
|
2008
|
0.84
|
|
9
|
Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene.
|
J Hepatol
|
2005
|
0.83
|
|
10
|
Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics.
|
Nagoya J Med Sci
|
2012
|
0.83
|
|
11
|
Biochemical staging of the chronic hepatic lesions of Wilson disease.
|
Nagoya J Med Sci
|
2014
|
0.82
|
|
12
|
Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
|
Hepatogastroenterology
|
2005
|
0.82
|
|
13
|
Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes.
|
Biochim Biophys Acta
|
2008
|
0.81
|
|
14
|
High prevalence of fulminant hepatic failure among patients with mutant alleles for truncation of ATP7B in Wilson's disease.
|
Scand J Gastroenterol
|
2010
|
0.81
|
|
15
|
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
|
J Gastroenterol
|
2010
|
0.81
|
|
16
|
Copper- and iron-rich matrices in hepatocellular lipofuscin particles of a young male patient: diagnostic ultrastructures for Wilson disease.
|
Ultrastruct Pathol
|
2006
|
0.80
|
|
17
|
Clinicopathological study of Japanese patients with genetic iron overload syndromes.
|
Pathol Int
|
2012
|
0.80
|
|
18
|
Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis.
|
Blood Cells Mol Dis
|
2012
|
0.80
|
|
19
|
Potentiation of vasoconstrictor response and inhibition of endothelium-dependent vasorelaxation by gallic acid in rat aorta.
|
Planta Med
|
2002
|
0.79
|
|
20
|
Identification of a novel 2026G-->C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome.
|
J Hum Genet
|
2003
|
0.78
|
|
21
|
Increasing and decreasing phases of ferritin and hemosiderin iron determined by serum ferritin kinetics.
|
Nagoya J Med Sci
|
2013
|
0.78
|
|
22
|
Effects of catechins on vascular tone in rat thoracic aorta with endothelium.
|
Life Sci
|
2002
|
0.77
|
|
23
|
Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.
|
Eur J Haematol
|
2011
|
0.77
|
|
24
|
Hepcidin expression in iron overload diseases is variably modulated by circulating factors.
|
PLoS One
|
2012
|
0.77
|
|
25
|
Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan.
|
J Gastroenterol
|
2005
|
0.77
|
|
26
|
AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis.
|
Hepatol Res
|
2003
|
0.77
|
|
27
|
A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.
|
Clin J Gastroenterol
|
2014
|
0.77
|
|
28
|
Endothelium-dependent contraction of rat thoracic aorta induced by gallic acid.
|
Phytother Res
|
2003
|
0.75
|
|
29
|
Improvement of serum bilirubin levels after venesection in a patient with Dubin-Johnson syndrome and HCV-positive chronic liver disease.
|
J Gastroenterol
|
2004
|
0.75
|
|
30
|
Reduction of MDR3 mRNA levels by forskolin in Chang liver cells.
|
Anticancer Res
|
2003
|
0.75
|
|
31
|
Investigation of the structure of cellulose in LiCl/DMAc solution and its gelation behavior by small-angle X-ray scattering measurements.
|
Macromol Biosci
|
2006
|
0.75
|
|
32
|
Mutation analysis of the multidrug resistance protein 2 (MRP2) gene in a Japanese patient with Dubin-Johnson syndrome.
|
Hepatol Res
|
2004
|
0.75
|
|
33
|
Two male patients with Wilson's disease treated using trientine and iron reduction therapy.
|
J Gastroenterol Hepatol
|
2005
|
0.75
|
|
34
|
Preliminary study of spontaneous hepatitis in Long-Evans Cinnamon rats: a blood exchange may improve fetal hepatitis.
|
Nagoya J Med Sci
|
2010
|
0.75
|
|
35
|
Protein kinase Cbeta isoform down-regulates the expression of MDR3 P-glycoprotein in human Chang liver cells.
|
Biochim Biophys Acta
|
2006
|
0.75
|
|
36
|
[Iron reduction therapy by phlebotomy for chronic hepatitis C].
|
Nihon Rinsho
|
2011
|
0.75
|